Bath & Body Works, Inc. is grappling with significant financial challenges as it reports a 1% revenue decline and cuts its earnings forecast from $3.28 to a minimum of $2.83 per diluted share. This turmoil is compounded by a 24.8% drop in stock price and multiple class action lawsuits alleging violations of securities laws due to misleading statements. While UBS has raised its price target to $22, investor confidence remains shaky, especially following the launch of its first authorized storefront on Amazon, which aims to improve market presence.
“Bath & Body Works, Inc. · is included among · Value Stocks to Buy with High Dividend Yields · 14”
“UBS · raised its price recommendation on Bath & Body Works, Inc. · price target · $22”
“Bath & Body Works · officially launched on · Amazon · February 20”
“Bath & Body Works · has a presence in · college campus stores · more than 1,000”
“Bath & Body Works · operates as a · global omnichannel retailer · focused on personal care and home fragrance”
“Bath and Body Works (NYSE:BBWI) · fell · 3.3% · afternoon session”
“Rosen Law Firm · reminds · purchasers of securities of Bath & Body Works, Inc. · important March 16, 2026 lead plaintiff deadline”
“Bath & Body Works · was unlikely to meet · its own previously issued financial guidance”
“defendants’ positive statements about Bath & Body Works · were · materially misleading and/or lacked a reasonable basis”
“Bath & Body Works, Inc. · alleges that · Defendants made materially false and/or misleading statements · regarding Bath & Body Works’s growth of its customer base and net sales between June 4, 2024 and November 19, 2025”
“Bronstein, Gewirtz & Grossman, LLC · announces · a class action lawsuit · against Bath & Body Works, Inc.”
“Bath & Body Works · launches · PEEPS® collaboration · limited-time collection”
